Claris Lifesciences Ltd (533288)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Claris Lifesciences Ltd (533288) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013108
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company offers generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. Its products are offered through various delivery systems such as bags, vials, ampoules, cartridges, glass bottles and plastic bottles. It manufactures and markets products in different markets and therapeutic segments including anesthesia and analgesia, nutrition, blood products, anti-infectives, orphan diseases, hormonal disorders, renal and transplant, oncology and critical care. The company serves institutions, government and private hospitals, aid agencies, and nursing homes. It operates through its manufacturing facility located in Ahmedabad, Gujarat. Claris is headquartered in Ahmedabad, Gujarat, India.

Claris Lifesciences Ltd (533288) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Claris Lifesciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
OrbiMed Advisors Acquires Minority Stake In Claris Lifesciences For US$4 Million 11
Signet Healthcare Partners Acquires 2.2% Stake In Claris Lifesciences For US$4 Million 12
Partnerships 13
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 13
Claris Lifesciences Enters Into Distribution Agreement With Stravencon 14
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 15
Acquisition 17
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 17
Baxter Acquires Claris Injectables for USD625 Million 18
Claris Lifesciences Ltd – Key Competitors 20
Claris Lifesciences Ltd – Key Employees 21
Claris Lifesciences Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 23
Recent Developments 24
Financial Announcements 24
Aug 31, 2016: Claris Lifescience: Q1 FY17 – Results Update 24
Mar 31, 2016: Claris Lifesciences Provides Q4 FY16 Results Update 25
Legal and Regulatory 26
Aug 26, 2016: Claris Update on the PAI US FDA Inspection 26
May 30, 2016: Claris Announces Receipt of EIR from the US FDA 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Claris Lifesciences Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Claris Lifesciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
OrbiMed Advisors Acquires Minority Stake In Claris Lifesciences For US$4 Million 11
Signet Healthcare Partners Acquires 2.2% Stake In Claris Lifesciences For US$4 Million 12
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 13
Claris Lifesciences Enters Into Distribution Agreement With Stravencon 14
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 15
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 17
Baxter Acquires Claris Injectables for USD625 Million 18
Claris Lifesciences Ltd, Key Competitors 20
Claris Lifesciences Ltd, Key Employees 21
Claris Lifesciences Ltd, Subsidiaries 22
Claris Lifesciences Ltd, Joint Venture 23

★海外企業調査レポート[Claris Lifesciences Ltd (533288)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Industrija nafte d.d. (INA-R-A):石油・ガス:M&Aディール及び事業提携情報
    Summary Industrija nafte dd (INA) is an integrated energy company, which operates across the energy value chain from exploration and production to refining and marketing to retail. It has interests in offshore and onshore assets in Croatia, Egypt, and Angola. The company manages refineries in Rijeka …
  • Close Brothers Group Plc:企業の戦略・SWOT・財務情報
    Close Brothers Group Plc - Strategy, SWOT and Corporate Finance Report Summary Close Brothers Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ferro Corp (FOE):企業の財務・戦略的SWOT分析
    Ferro Corp (FOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Living Cell Technologies Ltd (LCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT …
  • SThree Plc (STHR):企業の財務・戦略的SWOT分析
    Summary SThree Plc (Sthree) is a staffing company that offers permanent and contract staffing business. The company operates through its sectors such as information and communications technology (ICT), energy, engineering, life sciences, banking and finance. Its business brands such as Computer Futu …
  • Peabody Energy Corp:企業の戦略・SWOT・財務分析
    Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • QEP Resources Inc (QEP):企業の財務・戦略的SWOT分析
    QEP Resources Inc (QEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • NGEx Resources Inc:企業の戦略・SWOT・財務情報
    NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report Summary NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CMI Ltd (CMI):企業の財務・戦略的SWOT分析
    CMI Ltd (CMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Translate Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lonestar Heart Inc (Lonestar Heart) is a pharmaceutical company that focuses on the development of novel cardiac restorative therapies for advanced heart failure. The company offers Algisyl cardiac implantable hydrogel and MyoTec system. Its Algisyl product provides a new treatment option fo …
  • Advanced Marker Discovery SL-医療機器分野:企業M&A・提携分析
    Summary Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company offers test products and diagnostic tools for lung cancer, colon cancer and prostate cancer. It provides diagnostic tools that support the physician’s decisions about patient manage …
  • Luxembourg Institute of Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Luxembourg Institute of Health (LIH), formerly Centre de Recherche Public de la Sante is a biomedical research organisation that offers pre-clinical and clinical research in the areas of biomedicine and healthcare. The organization offers research under various departments such as infection …
  • Phagelux Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includ …
  • Vinnolit GmbH & Co KG:企業の戦略的SWOT分析
    Vinnolit GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor w …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • Lear Corp (LEA):企業の財務・戦略的SWOT分析
    Lear Corp (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Malayan Flour Mills Berhad:企業の戦略・SWOT・財務分析
    Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆